应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02269 药明生物
休市中 05-10 16:08:22
14.660
+0.080
+0.55%
最高
14.740
最低
14.160
成交量
6,055万
今开
14.700
昨收
14.580
日振幅
3.98%
总市值
624.61亿
流通市值
624.61亿
总股本
42.61亿
成交额
8.77亿
换手率
1.42%
流通股本
42.61亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
药明生物(02269)下跌2.61%,报14.2元/股
金融界 · 05-10 10:13
药明生物(02269)下跌2.61%,报14.2元/股
药明生物05月09日主力净流入5191万元 散户资金抛售
自选股智能写手 · 05-09 16:15
药明生物05月09日主力净流入5191万元 散户资金抛售
药明生物(02269)出现大手买入54.6万股,成交价$14.5,涉资791.7万
阿斯达克财经 · 05-09 15:45
药明生物(02269)出现大手买入54.6万股,成交价$14.5,涉资791.7万
药明生物领涨CRO概念股:康龙化成、药明康德紧跟其后
和讯网 · 05-09 12:20
药明生物领涨CRO概念股:康龙化成、药明康德紧跟其后
CRO概念股早盘普涨 药明生物及康龙化成均涨超5%
新浪港股 · 05-09 11:45
CRO概念股早盘普涨 药明生物及康龙化成均涨超5%
港股异动 | 药明生物(02269)涨超5%领涨CRO概念 融资环境有望改善 市场持续关注美生物法案进展
智通财经 · 05-09 11:19
港股异动 | 药明生物(02269)涨超5%领涨CRO概念 融资环境有望改善 市场持续关注美生物法案进展
创新药板块走势强劲 药明生物(02269)涨5.1% 光大证券坚定看好创新药产业链
金吾资讯 · 05-09 10:34
创新药板块走势强劲 药明生物(02269)涨5.1% 光大证券坚定看好创新药产业链
港股CXO概念震荡走强 药明生物涨超5%
南方财经网 · 05-09 10:03
港股CXO概念震荡走强 药明生物涨超5%
药明生物(02269)上涨5.1%,报14.84元/股
金融界 · 05-09 09:55
药明生物(02269)上涨5.1%,报14.84元/股
药明生物(02269)股价上升5.099%,现价港币$14.84
阿斯达克财经 · 05-09 09:55
药明生物(02269)股价上升5.099%,现价港币$14.84
药明生物(02269)下跌2.08%,报14.12元/股
金融界 · 05-08 13:01
药明生物(02269)下跌2.08%,报14.12元/股
《大行》瑞银降药明生物(02269.HK)目标价至16.6元 评级“中性”
阿斯达克财经 · 05-08
《大行》瑞银降药明生物(02269.HK)目标价至16.6元 评级“中性”
药明生物5月7日斥资1982.92万港元回购137万股
新浪港股 · 05-08
药明生物5月7日斥资1982.92万港元回购137万股
药明生物(02269.HK)回购137万股 涉资1,983万元
阿斯达克财经 · 05-08
药明生物(02269.HK)回购137万股 涉资1,983万元
药明生物(02269)5月7日斥资1982.92万港元回购137万股
智通财经网 · 05-07
药明生物(02269)5月7日斥资1982.92万港元回购137万股
药明生物(02269)5月7日斥资1982.92万港元回购137万股
智通财经 · 05-07
药明生物(02269)5月7日斥资1982.92万港元回购137万股
药明生物(02269)下跌2.02%,报14.56元/股
金融界 · 05-07
药明生物(02269)下跌2.02%,报14.56元/股
药明生物(02269)出现大手买入58.85万股,成交价$14.6,涉资859.21万
阿斯达克财经 · 05-07
药明生物(02269)出现大手买入58.85万股,成交价$14.6,涉资859.21万
药明系淡出行业重要会议,股价反而大涨
健识局 · 05-06
药明系淡出行业重要会议,股价反而大涨
智通港股解盘 | A股补涨增量继续推升港股 需要警惕进攻拉法
智通财经 · 05-06
智通港股解盘 | A股补涨增量继续推升港股 需要警惕进攻拉法
加载更多
公司概况
公司名称:
药明生物
所属市场:
SEHK
上市日期:
--
主营业务:
药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物(ADC)技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地,为客户生产疫苗以供应全球市场。该公司于中国市场及北美,欧洲和其他海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":14.66,"timestamp":1715328502015,"preClose":14.58,"halted":0,"volume":60551883,"delay":0,"floatShares":4260615669,"shares":4260615669,"eps":0.88308984,"marketStatus":"休市中","marketStatusCode":7,"change":0.08,"latestTime":"05-10 16:08:22","open":14.7,"high":14.74,"low":14.16,"amount":876644738,"amplitude":0.039781,"askPrice":14.66,"askSize":484500,"bidPrice":14.64,"bidSize":178500,"shortable":3,"etf":0,"ttmEps":0.8356317449711634,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715563800000},"adr":0,"listingDate":1497283200000,"adjPreClose":14.58,"adrRate":0,"openAndCloseTimeList":[[1715304600000,1715313600000],[1715317200000,1715328000000]],"volumeRatio":1.100492501517452,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1716998400000,"strike":"16.00","timestamp":1715304935185,"price":0.6800000071525574,"volume":464,"amount":157760,"type":"*"},{"symbol":"WXB.HK","call":true,"expireDate":1716998400000,"strike":"23.00","timestamp":1715304985108,"price":0.05000000074505806,"volume":336,"amount":8400,"type":"+"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK"},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2434072293","title":"药明生物(02269)下跌2.61%,报14.2元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434072293","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434072293?lang=zh_cn&edition=full","pubTime":"2024-05-10 10:13","pubTimestamp":1715307199,"startTime":"0","endTime":"0","summary":"5月10日,药明生物(02269)盘中下跌2.61%,截至10:13,报14.2元/股,成交3.01亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2023年年报,药明生物营业总收入170.34亿元、净利润34.0亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/10101340594312.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434068631","title":"药明生物05月09日主力净流入5191万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2434068631","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434068631?lang=zh_cn&edition=full","pubTime":"2024-05-09 16:15","pubTimestamp":1715242536,"startTime":"0","endTime":"0","summary":"05月09日, 药明生物股价涨3.26%,报收14.58元,成交金额9.52亿元,换手率1.52%,振幅6.09%,量比1.34。药明生物今日主力资金净流入5191万元,上一交易日主力净流出2479万元。该股近5个交易日下跌0.41%,主力资金累计净流入7321万元;近20日主力资金累计净流入2.26亿元,其中净流入天数为8日。该股主力净额占比0.08%,港股市场排名106/2623。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050916160087e3c3ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050916160087e3c3ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434057121","title":"药明生物(02269)出现大手买入54.6万股,成交价$14.5,涉资791.7万","url":"https://stock-news.laohu8.com/highlight/detail?id=2434057121","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2434057121?lang=zh_cn&edition=full","pubTime":"2024-05-09 15:45","pubTimestamp":1715240700,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午03:45出现大手买入,成交量为54.6万,成交价为港币$14.5,涉资791.7万。至目前为止,股价升2.55%,今日最高价为$15.04,而最低价为$14.18,总成交量为6.047千万股,总成交金额港币$8.883亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2405094113/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2434037426","title":"药明生物领涨CRO概念股:康龙化成、药明康德紧跟其后","url":"https://stock-news.laohu8.com/highlight/detail?id=2434037426","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2434037426?lang=zh_cn&edition=full","pubTime":"2024-05-09 12:20","pubTimestamp":1715228445,"startTime":"0","endTime":"0","summary":"快讯正文【CRO概念股集体飙升 药明生物领涨5.24%】今日早盘,CRO概念股迎来集体大涨,药明生物以5.24%的涨幅领涨,股价报14.86港元;康龙化成紧随其后,涨幅达5.17%,报10.38港元;药明康德和泰格医药也表现亮眼,涨幅分别为3.85%和3.58%,股价分别为37.80港元和36.15港元。这一轮涨势反映出市场对CRO行业的高度关注和期待,同时也显示出投资者对相关企业的信心。下载和讯APP查看快讯,体验更佳>>","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405091304488aeb3bdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405091304488aeb3bdb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434031428","title":"CRO概念股早盘普涨 药明生物及康龙化成均涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434031428","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2434031428?lang=zh_cn&edition=full","pubTime":"2024-05-09 11:45","pubTimestamp":1715226341,"startTime":"0","endTime":"0","summary":"CRO概念股早盘普涨,药明生物(02269)涨5.24%,报14.86港元;康龙化成(03759)涨5.17%,报10.38港元;药明康德(02359)涨3.85%,报37.80港元;泰格医药(03347)涨3.58%,报36.15港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-09/doc-inauraum9624670.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-09/doc-inauraum9624670.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434073036","title":"港股异动 | 药明生物(02269)涨超5%领涨CRO概念 融资环境有望改善 市场持续关注美生物法案进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2434073036","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434073036?lang=zh_cn&edition=full","pubTime":"2024-05-09 11:19","pubTimestamp":1715224780,"startTime":"0","endTime":"0","summary":"光大证券表示,随着美债利率回落,市场风险偏好有可能上升,利好创新药类的风险资产进入估值上升通道。该行指出,随着美国生物法案的进展,尤其是现有合同的处理方式将更加明朗。目前投资者假设包括法案将以某种形式获得通过;法案应该不会像看起来般严厉,并估计药明生物以至中国同行的新项目将在未来3至5年内来自欧盟、中国、世界其它地区,而不是美国。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1119138.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434339610","title":"创新药板块走势强劲 药明生物(02269)涨5.1% 光大证券坚定看好创新药产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2434339610","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2434339610?lang=zh_cn&edition=full","pubTime":"2024-05-09 10:34","pubTimestamp":1715222086,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块走势强劲,百济神州(06160)涨6.96%,东阳光长江药业(01558)涨6%,药明生物(02269)涨5.1%,康龙化成(03759)涨4.56%,中生制药(01177)涨4.47%,康希诺生物(06185)涨4.25%,药明康德(02359)涨4.12%。光大证券表示,随着美债利率回落,市场风险偏好有可能上升,利好创新药类的风险资产进入估值上升通道。未来进入降息通道之后,良好的利率环境带来融资改善,将推动远期创新产业链的长足发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050910351087e291de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050910351087e291de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434801440","title":"港股CXO概念震荡走强 药明生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434801440","media":"南方财经网","top":-1,"share":"https://www.laohu8.com/m/news/2434801440?lang=zh_cn&edition=full","pubTime":"2024-05-09 10:03","pubTimestamp":1715220197,"startTime":"0","endTime":"0","summary":"南方财经5月9日电,港股CXO概念震荡走强,药明生物涨超5%,康龙化成、药明康德涨超4%,金斯瑞生物科技、昭衍新药等跟涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202405093071213978.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434608067","title":"药明生物(02269)上涨5.1%,报14.84元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434608067","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434608067?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:55","pubTimestamp":1715219745,"startTime":"0","endTime":"0","summary":"5月9日,药明生物(02269)盘中上涨5.1%,截至09:55,报14.84元/股,成交2.57亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2023年年报,药明生物营业总收入170.34亿元、净利润34.0亿元。5月7日,公司以每股14.4-14.6港元回购137万股,回购金额1983万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/09095540576927.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434038356","title":"药明生物(02269)股价上升5.099%,现价港币$14.84","url":"https://stock-news.laohu8.com/highlight/detail?id=2434038356","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2434038356?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:55","pubTimestamp":1715219700,"startTime":"0","endTime":"0","summary":"[上升股]药明生物(02269) 股价在上午09:55比前收市价上升5.099%,现股价为港币$14.84。至目前为止,今日最高价为$14.84,而最低价为$14.18。总成交量为1.747千万股,总成交金额为港币$2.553亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240509826/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2433291796","title":"药明生物(02269)下跌2.08%,报14.12元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433291796","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433291796?lang=zh_cn&edition=full","pubTime":"2024-05-08 13:01","pubTimestamp":1715144498,"startTime":"0","endTime":"0","summary":"5月8日,药明生物(02269)盘中下跌2.08%,截至13:01,报14.12元/股,成交3.04亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2023年年报,药明生物营业总收入170.34亿元、净利润34.0亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/08130140561712.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433761414","title":"《大行》瑞银降药明生物(02269.HK)目标价至16.6元 评级“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2433761414","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2433761414?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:50","pubTimestamp":1715133000,"startTime":"0","endTime":"0","summary":"瑞银发表研究报告指,药明生物维持2024年指引,并重申2024年收入按年升5%至10%属高可能性,因为大部分属积存订单。瑞银表示,公司强调2024年至2027年的资本支出主要用在海外产能扩张,2024年新增产能有限。爱尔兰生产基地继续提高产能利用率,2025年的产能几乎已被全部预订。该行下调对其今明两年盈测分别7.3%和6.3%,将目标价由17.6元降至16.6元,维持“中性”评级。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190228123307735_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190228123307735_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1348028/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2433752167","title":"药明生物5月7日斥资1982.92万港元回购137万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433752167","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2433752167?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:03","pubTimestamp":1715126637,"startTime":"0","endTime":"0","summary":"药明生物(02269)发布公告,于2024年5月7日,该公司斥资1982.92万港元回购137万股,每股回购价为14.4-14.6港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-08/doc-inaunpfi8415376.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-08/doc-inaunpfi8415376.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433532738","title":"药明生物(02269.HK)回购137万股 涉资1,983万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433532738","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2433532738?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:09","pubTimestamp":1715101740,"startTime":"0","endTime":"0","summary":"药明生物(02269.HK) 报表披露,5月7日,于联交所回购137万股,每股作价介乎14.4-14.6元,总代价约1,983万元。自普通决议案通过至今,公司累计回购9,798.2万股,占股本2.30632%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-05-07 16:25。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1347928/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2433783526","title":"药明生物(02269)5月7日斥资1982.92万港元回购137万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433783526","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2433783526?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:02","pubTimestamp":1715090579,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明生物(02269)发布公告,于2024年5月7日,该公司斥资1982.92万港元回购137万股,每股回购价为14.4-14.6港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118498.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433523783","title":"药明生物(02269)5月7日斥资1982.92万港元回购137万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433523783","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433523783?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:02","pubTimestamp":1715090579,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明生物(02269)发布公告,于2024年5月7日,该公司斥资1982.92万港元回购137万股,每股回购价为14.4-14.6港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072203568ae53699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072203568ae53699&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433299939","title":"药明生物(02269)下跌2.02%,报14.56元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433299939","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433299939?lang=zh_cn&edition=full","pubTime":"2024-05-07 11:07","pubTimestamp":1715051261,"startTime":"0","endTime":"0","summary":"5月7日,药明生物(02269)盘中下跌2.02%,截至11:07,报14.56元/股,成交3.02亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2023年年报,药明生物营业总收入170.34亿元、净利润34.0亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/07110740542806.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433629305","title":"药明生物(02269)出现大手买入58.85万股,成交价$14.6,涉资859.21万","url":"https://stock-news.laohu8.com/highlight/detail?id=2433629305","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2433629305?lang=zh_cn&edition=full","pubTime":"2024-05-07 10:34","pubTimestamp":1715049240,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午10:34出现大手买入,成交量为58.85万,成交价为港币$14.6,涉资859.21万。至目前为止,股价跌1.884%,今日最高价为$14.94,而最低价为$14.52,总成交量为1.663千万股,总成交金额港币$2.444亿。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2405071997/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2433471186","title":"药明系淡出行业重要会议,股价反而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2433471186","media":"健识局","top":-1,"share":"https://www.laohu8.com/m/news/2433471186?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:21","pubTimestamp":1715001688,"startTime":"0","endTime":"0","summary":"要知道,药明生物、药明康德早在2020年就一直作为与会者参加该活动,但今年3月,药明康德终止了BIO会员资格。药明康德和药明生物不在今年的BIO年会中举办展览,在投资者意料之中。二级市场层面,5月6日,药明生物并未受影响,反而以大涨6.45%收盘。BIO年会是行业里有号召力的大会,每年约有两万多名来自全球的生物技术从业人员参加。去年,BIO官方就曾披露,中国企业参会积极性较高,全球排名位列第七。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621302587d89eb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621302587d89eb1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433200114","title":"智通港股解盘 | A股补涨增量继续推升港股 需要警惕进攻拉法","url":"https://stock-news.laohu8.com/highlight/detail?id=2433200114","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433200114?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:23","pubTimestamp":1714998233,"startTime":"0","endTime":"0","summary":"五一假期,港股持续上涨,A股今天开市自然要补涨,而港股则继续往上拓展空间。均涨幅在6个点。苹果在公布财报后,大手笔回购1100亿美元才稳住了股价。据媒体报道,当地时间6日,以色列军方表示,他们正在从拉法东部撤离大约10万人。报道称,以军预计将对加沙南部城市拉法展开地面进攻。世界卫生组织表示,目前约有120万人在拉法避难。此前,以色列方面已多次表示将进攻拉法。另外,天然气涨价也是其中重要因素。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117834.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0501},{"period":"1month","weight":0.0223},{"period":"3month","weight":-0.1536},{"period":"6month","weight":-0.6999},{"period":"1year","weight":-0.6854},{"period":"ytd","weight":-0.5047}],"compareEarnings":[{"period":"1week","weight":0.0264},{"period":"1month","weight":0.1065},{"period":"3month","weight":0.2043},{"period":"6month","weight":0.1023},{"period":"1year","weight":-0.0395},{"period":"ytd","weight":0.1124}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物(ADC)技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地,为客户生产疫苗以供应全球市场。该公司于中国市场及北美,欧洲和其他海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.035713},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034807},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.00624},{"month":4,"riseRate":0.428571,"avgChangeRate":0.021731},{"month":5,"riseRate":0.571429,"avgChangeRate":0.025024},{"month":6,"riseRate":0.5,"avgChangeRate":0.075451},{"month":7,"riseRate":0.714286,"avgChangeRate":0.068513},{"month":8,"riseRate":0.571429,"avgChangeRate":0.03818},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.041003},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.017109},{"month":11,"riseRate":0.571429,"avgChangeRate":0.064498},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.013887}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}